Humulus 6X, 15X Homeopathic Pills Recalled for Failed Testing
Washington Homeopathic Products is recalling Humulus 6X and 15X homeopathic pills distributed nationwide due to out-of-specification test results from identification testing.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: This is an FDA Class II recall involving a homeopathic product with failed identification testing. No reported illnesses or injuries are mentioned in the source text, and the hazard is based on out-of-specification laboratory results rather than an identified health threat, placing this in the Moderate category.
Plain-English summary
Washington Homeopathic Products, Inc. is recalling Humulus 6X and 15X Sucrose/Lactose Pills nationwide. The recall was initiated because the product failed identification testing based on HPTLC (high-performance thin-layer chromatography) analysis, with results falling outside specifications.
The affected products include Humulus 6X in 4-dram bottles (UPC 7 40640 33969 5) and Humulus 15X in 4-dram bottles. The specific lot number 29298 with expiration date 8/17/2026 is involved.
Consumers who have purchased this product should stop using it. Patients or healthcare providers with questions about this recall or the product may contact the FDA or Washington Homeopathic Products for further information.
The recalled product
- Product
- Humulus 6X, 15X, Sucrose/Lactose Pills, 6X Packaged as a) 4dr, UPC 7 40640 33969 5; 15X Packaged as b) 4 dr; WHP Homeopathic Medicine. Washington Homeopathic Products, 260 JR Hawvermale Way, Berkeley Springs, WV 25411.
- Manufacturer
- Washington Homeopathic Products, Inc.
- Category
- Drug — Homeopathic
- Hazard
- out-of-specification-testing
- failed-identification-testing
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot # 29298
- Exp 8/17/2026
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- ModerateGas-X Simethicone 125 mg softgels recall for incomplete labeling
FDA (Drugs) · 2026-05-27
- ModerateVitamin B-Complex, Vitamin C & Folic Acid Dietary Supplement Oral Liquid
FDA (Drugs) · 2026-05-27